Article Information
PubMed
Print ISSN
Online ISSN
History
- Received January 14, 2012
- Accepted May 7, 2012
- Published online July 17, 2012.
Article Versions
- Earlier version (May 7, 2012 - 11:16).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Respiratory and Inflammation DMPK, AstraZeneca R&D, Mölndal, Sweden (S.A.P.); Oncology DMPK, AstraZeneca R&D, Boston, MA (P.E.S., N.G.); and Global DMPK, AstraZeneca R&D, Mölndal, Sweden (H.D.)
- Address correspondence to:
Dr. Sheila Annie Peters, Respiratory and Inflammation DMPK, AstraZeneca R&D, Mölndal, SE 43183 Mölndal, Sweden. E-mail: sheila.peters{at}astrazeneca.com
This work was previously presented in part as follows: Peters S, Schroeder P, and Giri N (2011) Evaluation of clinical drug-drug interactions using static and dynamic models: a retrospective analysis. Drug-Drug Interaction Prediction Workshop; 6–7 Jun 2011; Silver Spring, MD. U.S. Food and Drug Administration, Silver Spring, MD, and Leadership Group of the International Consortium for Innovation and Quality in Pharmaceutical Development, http://iqconsortium.com/.